Literature DB >> 31531806

Liraglutide promotes autophagy by regulating the AMPK/mTOR pathway in a rat remnant kidney model of chronic renal failure.

Lingyu Xue1, Zhanglei Pan2, Qiao Yin2, Peng Zhang2, Jing Zhang2, Wenwen Qi2.   

Abstract

BACKGROUND: We aimed to determine whether the glucagon-like peptide-1 receptor (GLP-1R) agonist liraglutide (LRG) could ameliorate renal function through promoting autophagy via regulating the AMPK/mTOR pathway in a rat remnant kidney model of chronic renal failure.
METHODS: Rats were divided into four groups (n = 10 per group) as follows: (1) sham, (2) nephrectomy (NPX), (3) LRG control (LRG control), and (4) LRG treatment (LRG). Except for rats in the sham group, all rats underwent 5/6 nephrectomy surgery to establish a remnant kidney model of chronic renal failure. In addition, rats in LRG group received LRG as a subcutaneous injection at a dose of 10 mg/kg (once daily) for 4 consecutive weeks, whereas rats in the LRG control group received treatment similar to that of rats in the LRG group, except saline was used instead of LRG. After 4 weeks of treatment, serum creatinine (Scr), blood urea nitrogen (BUN), and urinary albumin excretion were determined. Immunofluorescence assay, immunoprecipitation assay, and Western blot analysis were performed to evaluate the AMPK/mTOR pathway expression of proteins.
RESULTS: Nephrectomized rats (including rats in the NPX, LRG control, and LRG groups) showed higher levels of the Scr, BUN, and urinary albumin excretion, as well as down-regulation of GLP-1R, LC3-II, and AMPK phosphorylation, and up-regulation of mTOR phosphorylation when compared with rats in the sham group. However, those changes were blocked by liraglutide.
CONCLUSION: Liraglutide may promote autophagy through regulating the AMPK/mTOR pathway to exert renoprotective effects in a rat remnant kidney model of chronic renal failure.

Entities:  

Keywords:  AMPK/mTOR pathway; Autophagy; Chronic kidney disease; Liraglutide; Remnant kidney

Mesh:

Substances:

Year:  2019        PMID: 31531806     DOI: 10.1007/s11255-019-02274-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  34 in total

Review 1.  Deregulation of autophagy and vesicle trafficking in Parkinson's disease.

Authors:  Patricia Sheehan; Zhenyu Yue
Journal:  Neurosci Lett       Date:  2018-04-05       Impact factor: 3.046

2.  Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor.

Authors:  B P Bullock; R S Heller; J F Habener
Journal:  Endocrinology       Date:  1996-07       Impact factor: 4.736

3.  Modulation of Kalirin-7 expression by hippocampal CA1 5-HT1B receptors in spatial memory consolidation.

Authors:  Meng-He Zhou; Fang-Fang Sun; Chang Xu; Hui-Bin Chen; Hui Qiao; Xiang Cai; Xin-Ming Ma; Shu-Cheng An
Journal:  Behav Brain Res       Date:  2018-06-24       Impact factor: 3.332

Review 4.  Autophagy in kidney disease and aging: lessons from rodent models.

Authors:  Olivia Lenoir; Pierre-Louis Tharaux; Tobias B Huber
Journal:  Kidney Int       Date:  2016-06-18       Impact factor: 10.612

Review 5.  GLP-1: benefits beyond pancreas.

Authors:  G Muscogiuri; A Cignarelli; F Giorgino; F Prodam; F Prodram; D Santi; G Tirabassi; G Balercia; R Modica; A Faggiano; A Colao
Journal:  J Endocrinol Invest       Date:  2014-08-09       Impact factor: 4.256

Review 6.  Chronic kidney disease epidemic: How do we deal with it?

Authors:  Jack K-C Ng; Philip K-T Li
Journal:  Nephrology (Carlton)       Date:  2018-10       Impact factor: 2.506

7.  Activation of autophagy contributes to the renoprotective effect of postconditioning on acute kidney injury and renal fibrosis.

Authors:  Yaolin Song; Qianyu Tao; Lixia Yu; Ling Li; Tingting Bai; Xiaoxiao Song; Haiqi Hu; Yulin Li; Xiaohua Tan
Journal:  Biochem Biophys Res Commun       Date:  2018-09-08       Impact factor: 3.575

Review 8.  Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer.

Authors:  Guangbo Liu; Fen Pei; Fengqing Yang; Lingxiao Li; Amit Dipak Amin; Songnian Liu; J Ross Buchan; William C Cho
Journal:  Int J Mol Sci       Date:  2017-02-10       Impact factor: 5.923

9.  Role of Neurexin-1β and Neuroligin-1 in Cognitive Dysfunction After Subarachnoid Hemorrhage in Rats.

Authors:  Haitao Shen; Zhouqing Chen; Yang Wang; Anju Gao; Haiying Li; Yonghua Cui; Li Zhang; Xiang Xu; Zhong Wang; Gang Chen
Journal:  Stroke       Date:  2015-07-28       Impact factor: 7.914

Review 10.  Autophagy modulation: a prudent approach in cancer treatment?

Authors:  Eleanor Bishop; Tracey D Bradshaw
Journal:  Cancer Chemother Pharmacol       Date:  2018-09-04       Impact factor: 3.333

View more
  5 in total

Review 1.  Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.

Authors:  Milton Packer
Journal:  J Am Soc Nephrol       Date:  2020-04-10       Impact factor: 10.121

2.  Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy.

Authors:  Yingfeng Shi; Min Tao; Xiaoyan Ma; Yan Hu; Guansen Huang; Andong Qiu; Shougang Zhuang; Na Liu
Journal:  Cell Death Dis       Date:  2020-06-17       Impact factor: 8.469

Review 3.  Research progress on the relationship between autophagy and chronic complications of diabetes.

Authors:  Xia Ge; Ling Wang; Aihua Fei; Shandong Ye; Qingping Zhang
Journal:  Front Physiol       Date:  2022-08-08       Impact factor: 4.755

Review 4.  Autophagy in renal fibrosis: Protection or promotion?

Authors:  Rong Dai; Lei Zhang; Hua Jin; Dong Wang; Meng Cheng; Tian Sang; Chuyi Peng; Yue Li; Yiping Wang
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

5.  Hydroxysafflor Yellow A inhibits the viability and migration of vascular smooth muscle cells induced by serum from rats with chronic renal failure via inactivation of the PI3K/Akt signaling pathway.

Authors:  Changliang Huo; Li Wang; Qiuli Wang; Yanbo Yang; Bo Chen
Journal:  Exp Ther Med       Date:  2021-06-08       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.